MedPath

This is the clinical study to know the effect of Palashapushpa darbhamula churna in pervaginal bleeding

Phase 2/3
Not yet recruiting
Conditions
Irregular menstruation, unspecified. Ayurveda Condition: Rakta pradara, (2) ICD-10 Condition: N921||Excessive and frequent menstruation with irregular cycle. Ayurveda Condition: Raktapradara, (3) ICD-10 Condition: N921||Excessive and frequent menstruation with irregular cycle,
Registration Number
CTRI/2023/05/052902
Lead Sponsor
Rakshitha KS
Brief Summary

This is the interventional single group clinical study To evaluate the efficacy of Palashapuspa Darbhamula Churna in Raktapradara w. s. r to DUB for 2 consecutive menstrual cycle for 10 days in 30 patients will be conducted in Alvas Ayurveda Medical Collage and Hospital Moodbidari Camps and Other referral.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Female
Target Recruitment
30
Inclusion Criteria

1.Patient fulfilling 2 or more diagnostic criteria(Raja atipravrthi,Deergakalanubandhi,Anruthavalpamapi,Angamarda and vedana) 2.Patient having excessive bleeding/prolonged bleeding/intermenstrual bleeding with history of minimum of 2 cycles.

Exclusion Criteria
  • 1.Patient with diagnosed case of Coagulation disorders, Hypertension, Diabetes mellitus, Thyroid dysfunction, Liver disease.
  • 2.Patients having Hb% below 8gm%.
  • 3.Post Abortal bleeding.
  • 4.Patient with Intrauterine Contraceptive devices and Oral Contraceptive pills.
  • 5.known case of organic and pelvic pathologies.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The changes in the symptoms before and after the medication will be scored as follows:During treatment- on 4th day, 7th day and 10th day. | After treatment- on 8th day of 3rd menstrual cycle.
Pictorial Blood Assessment Chart (PBAC) scoring.During treatment- on 4th day, 7th day and 10th day. | After treatment- on 8th day of 3rd menstrual cycle.
Pain will be assessed by VAS grading (visual analogue scale)During treatment- on 4th day, 7th day and 10th day. | After treatment- on 8th day of 3rd menstrual cycle.
Secondary Outcome Measures
NameTimeMethod
post interventional assessment will be done. Symptoms will be graded and score will be given accordingly.

Trial Locations

Locations (1)

Alvas ayurveda medical college

🇮🇳

Kannada, KARNATAKA, India

Alvas ayurveda medical college
🇮🇳Kannada, KARNATAKA, India
Rakshitha KS
Principal investigator
7019317207
ksrakshitha32@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.